OBJECTIVE: To identify the characteristics, treatments and hospital outcomes of patients diagnosed as having acute coronary syndrome (ACS) in the United Arab Emirates (UAE). DESIGN: A 3-year prospective registry. SETTING: Four tertiary care hospitals in three major cities of UAE from December 2003 to December 2006. PATIENTS: 1842 eligible consecutive patients with suspected ACS. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Characteristics, treatments and in-hospital outcomes were recorded. RESULTS: The mean age was 50.8±10.0 years, and 93.1% were male. More than half (51%) had ST elevation myocardial infarction (STEMI). The smoking rate was 46.4%, and diabetes was present in 38.9%. Only a minority (17.3%) used the ambulance services. For patients with STEMI, the median symptom to hospital time was 127 (IQR 60-256) min, and the median diagnostic ECG to thrombolysis time was 28 (IQR 16-50) min. Reperfusion in STEMI was in 81.4% (64.8% thrombolysis and 16.6% primary percutaneous coronary intervention). During hospitalisation, only a minority of the patients did not receive antiplatelets, anticoagulants, beta-blockers, ACE inhibitors and statin therapy. In-hospital complications were not common in our registry cohort. In-hospital mortality was 1.68%. CONCLUSIONS: ACS patients in UAE are young but have higher risk factors such as smoking and diabetes. Almost half present as STEMI. Only a minority use ambulance services.
OBJECTIVE: To identify the characteristics, treatments and hospital outcomes of patients diagnosed as having acute coronary syndrome (ACS) in the United Arab Emirates (UAE). DESIGN: A 3-year prospective registry. SETTING: Four tertiary care hospitals in three major cities of UAE from December 2003 to December 2006. PATIENTS: 1842 eligible consecutive patients with suspected ACS. INTERVENTIONS: None. MAIN OUTCOME MEASURES: Characteristics, treatments and in-hospital outcomes were recorded. RESULTS: The mean age was 50.8±10.0 years, and 93.1% were male. More than half (51%) had ST elevation myocardial infarction (STEMI). The smoking rate was 46.4%, and diabetes was present in 38.9%. Only a minority (17.3%) used the ambulance services. For patients with STEMI, the median symptom to hospital time was 127 (IQR 60-256) min, and the median diagnostic ECG to thrombolysis time was 28 (IQR 16-50) min. Reperfusion in STEMI was in 81.4% (64.8% thrombolysis and 16.6% primary percutaneous coronary intervention). During hospitalisation, only a minority of the patients did not receive antiplatelets, anticoagulants, beta-blockers, ACE inhibitors and statin therapy. In-hospital complications were not common in our registry cohort. In-hospital mortality was 1.68%. CONCLUSIONS: ACS patients in UAE are young but have higher risk factors such as smoking and diabetes. Almost half present as STEMI. Only a minority use ambulance services.
Authors: C P Cannon; A Battler; R G Brindis; J L Cox; S G Ellis; N R Every; J T Flaherty; R A Harrington; H M Krumholz; M L Simoons; F J Van De Werf; W S Weintraub; K R Mitchell; S L Morrisson; R G Brindis; H V Anderson; D S Cannom; W R Chitwood; J E Cigarroa; R L Collins-Nakai; S G Ellis; R J Gibbons; F L Grover; P A Heidenreich; B K Khandheria; S B Knoebel; H L Krumholz; D J Malenka; D B Mark; C R Mckay; E R Passamani; M J Radford; R N Riner; J B Schwartz; R E Shaw; R J Shemin; D B Van Fossen; E D Verrier; M W Watkins; D R Phoubandith; T Furnelli Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094
Authors: Andrzej Budaj; David Brieger; Ph Gabriel Steg; Shaun G Goodman; Omar H Dabbous; Keith A A Fox; Alvaro Avezum; Christopher P Cannon; Tomasz Mazurek; Marcus D Flather; Frans Van De Werf Journal: Am Heart J Date: 2003-12 Impact factor: 4.749
Authors: D Hasdai; S Behar; L Wallentin; N Danchin; A K Gitt; E Boersma; P M Fioretti; M L Simoons; A Battler Journal: Eur Heart J Date: 2002-08 Impact factor: 29.983
Authors: Mohammad Zubaid; Wafa A Rashed; Hisham Saad; Ali Attiya; Bassam Abu Al-Banat; Mustafa Ridha; Muhammad H Al-Kandari; Ghassan Baidas; Rashed Al-Hamdan; Shaheed Zubair; Lukman Thalib Journal: Med Princ Pract Date: 2007 Impact factor: 1.927
Authors: Lori Mandelzweig; Alex Battler; Valentina Boyko; Hector Bueno; Nicolas Danchin; Gerasimos Filippatos; Anselm Gitt; David Hasdai; Yonathan Hasin; Jaume Marrugat; Frans Van de Werf; Lars Wallentin; Shlomo Behar Journal: Eur Heart J Date: 2006-08-14 Impact factor: 29.983
Authors: Philippe Gabriel Steg; Robert J Goldberg; Joel M Gore; Keith A A Fox; Kim A Eagle; Marcus D Flather; Immad Sadiq; Rachel Kasper; Sophie K Rushton-Mellor; Frederick A Anderson Journal: Am J Cardiol Date: 2002-08-15 Impact factor: 2.778
Authors: Denis Xavier; Prem Pais; P J Devereaux; Changchun Xie; D Prabhakaran; K Srinath Reddy; Rajeev Gupta; Prashant Joshi; Prafulla Kerkar; S Thanikachalam; K K Haridas; T M Jaison; Sudhir Naik; A K Maity; Salim Yusuf Journal: Lancet Date: 2008-04-26 Impact factor: 79.321